This is an Open Access article licensed under the terms of the Creative Commons AttributionNonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only. Quantitative real-time PCR (qRT-PCR) was used to detect the mRNA level of miR-497. Luciferase assays, colony formation assays and BrdU incorporation assays were performed to identify the targets and role of miR-497 in NSCLC cells. Finally, the abundance of miR-497 was analyzed in a total of 51 NSCLC specimens. Results: The transcript levels of miR-497 were significantly decreased in NSCLC tissue (25/30; 83.3%). Low miR-497 levels in tumor tissue correlated with advanced pT stage. Additionally, miR-497 transcript levels correlated with overall survival of NSCLC patients (n = 51, p = 0.022). Overexpression of miR-497 inhibited the proliferation of NSCLC cell and down-regulation of miR-497 resulted in elevated NSCLC growth. Exogenous over-expression of YAP1 partially eliminated miR-497-induced cell growth. Conclusion: miR-497 plays an important role in inhibiting the proliferation of NSCLC by targeting YAP1. Our results suggest that miR-497 is a potential therapeutic target in treating patients with NSCLC.
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Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry strategies developed to date, the prognosis of NSCLC remains unsatisfactory. The 5-year survival rate of patients with NSCLC is less than 16% [3, 4] . MicroRNAs (miRNAs) are a class of small non-protein-coding RNAs of approximately 22 nucleotides in size that are endogenously expressed in mammalian cells. miRNAs can posttranscriptionally regulate the expression of hundreds of target genes, thereby acting as oncogenes or tumor suppressors by modulating a wide range of biological functions such as cellular proliferation [5, 6] , differentiation [7] , metastasis [6, 8] and apoptosis [9] . MiR-497, a highly conserved miRNA located at Chromosome 17p13.1 [10] , was recently found to play important inhibitory roles in malignancies by suppressing cancer cell proliferation [11] and inducing apoptosis [12] .
Yes-associated protein 1 (YAP1), a key molecule of the Hippo signaling pathway, has been implicated as an oncogene in many types of malignancies [13] . YAP1 promotes proliferation and tumor growth by regulating several context-specific transcriptional programs [14] . Because YAP1 had been screened out as a potential target of miR-497, the possibility that miR-497 inhibits NSCLC proliferation via targeting YAP1 is intriguing.
In this study, we verified that miR-497 plays an inhibitory role in tumor growth in NSCLC cells as previously reported [15] . In addition, we explored the clinical significance of miR-497 in NSCLC patients and discovered that the expression level of miR-497 was associated with the overall survival of patients with NSCLC. The expression level of YAP1 in NSCLC tumor tissues was negatively associated with the level of miR-497. An interference of miR-497 promotes the proliferation of NSCLC cells, whereas ectopic expression of miR-497 results in inhibited proliferation activity by inhibiting YAP1.
Materials and Methods

Cell lines and tumor specimens
All of the NSCLC cell lines used in this study were bought from the Cell Culture Center of the Shanghai Institute for Biological Sciences (Chinese Academy of Science, Shanghai, China), including five adenocarcinoma cell lines (A549, H1299, H358, H1975 and H1395); two squamous cell lines (H520 and SK-MES-1); and large cell carcinoma cell line, H460. The cancer cells were grown in monolayer in 1640 culture medium supplemented with 10% fetal bovine serum (FBS) and maintained at 37°C in humidified air with 5% CO2.
A total of 51 tumor tissue specimens and 30 corresponding adjacent normal lung tissues were obtained through the Tumor Tissue Bank of Tianjin Cancer Hospital from patients who underwent curative resection for NSCLC at the Tianjin Cancer Institute and Hospital (TJMUCH) between 2007 and 2008. The median follow-up time for overall survival (OS) was 48 months. This study was approved by the Ethics Committee of TJMUCH. All patients signed a written consent for the use of their specimens and disease information for future investigations according to the ethics committee.
SiRNA, miRNA, plasmid construction, transfection, and luciferase assays SiRNAs against miR-497 and YAP1 were designed as described [16, 17] . A scrambled siRNA sequence (5′ -UUCUCCGAACGUGUCACGUTT-3′) was used as a control. The overexpression of miR-497 mimics was described previously [18] . Non-targeting control (NTC) was used as a control. All of the RNAs were synthesized from Genepharma. The coding domain sequence of human YAP1 mRNA was cloned into pcDNA 3.1 vector (Invitrogen). For transfection, the cells were plated at a density of 5 x 10 5 cells/well in 6-well plates. When the cells reached 80% confluence, 100 pmol of siRNA or 4 µg of DNA were transfected into cells using Lipofectamine 3000 (Invitrogen) for 48 hours according to the manufacturer's instructions.
The 3'-untranslated region (UTR) of human YAP1 mRNA was amplified by PCR using the following primers: YAP1-3' UTR-F: 5'-ATG CAT AGT TTC TGC CCA AAGGT-3'; YAP1-3' UTR-R: 5'-GTT GCC TTT CCC CGC CTCCC-3', and cloned into the XhoI/NotI sites of the pmirGLO vector (Promega). All of the constructs were verified by sequencing. For the luciferase assays, HEK293T cells were seeded in 6-well plates and transfected with 4 μg of the pmirGLO-YAP1 3'-UTR reporter vector per well and 100 pmol of microRNA or control RNA using Lipofectamine 3000 (Invitrogen). Site-specific mutants of the 3'-UTR reporters for YAP1 were also tested.
Protein extraction and Western blot analysis
Whole-cell extracts were prepared by lysing cells with SDS lysis buffer supplemented with a protease inhibitor cocktail (Sigma). A total of 20 μg of protein lysates were separated by SDS-PAGE and then the target proteins were detected by Western blot analysis with the following primary antibodies: rabbit anti-human Yap1 monoclonal antibody (Abcam), and mouse anti-human Ki-67 polyclonal antibody (Abmart). After further washes, the membranes were incubated with the goat anti-rabbit/mouse peroxidase-conjugated secondary antibodies (Abcam), and the blots were developed using ECL (Millipore).
RNA extraction and Real-time PCR
Total RNA of the cells and the tissues was extracted using Trizol (Invitrogen) according to the manufacturer's instructions. Then, a total of 3 μg of mRNA was reverse transcribed to single-stranded cDNAs using a reverse-transcription PCR (RT-PCR) system (TaKaRa). qRT-PCR for miR-497, YAP1 and c-myc were performed using SYBR premix real-time PCR Reagent (TaKaRa). The primers for miR-497, U6 and c-myc were listed elsewhere [19, 20] . The primer sequences for YAP1 and β-actin were as follows: YAP1 (5' -AGA ACA ATG ACG ACC AAT AGCTC-3', 3' -GCT GCT CAT GCT TAG TCCAC-5'), β-actin (5' -CCT GGG CAT GGA GTC CTGTG-3', 3' -AGG GGC CGG ACT CGT CATAC-5'). The 25-μL PCR reaction mixture contained: 2 μL of reverse transcription product, 1×PCR Master Mix and 0.2 μmol/L forward and reverse primers. U6 RNA was used to normalize the miR-497 RNA levels and β-actin was used to normalize the level of other mRNAs. The results are presented as fold change in cells or tissues.
Immunohistochemical staining
Immunohistochemical staining for YAP1 of NSCLC patient tissues was performed according to the manufacturer's instructions. In brief, paraffin-embedded sections of NSCLC tissue micro arrays were deparaffinized and then heated in a pressure pot for 3 minutes for antigen retrieval. Then, the sections were incubated with rabbit anti-human YAP1 monoclonal antibody at a 1:500 dilution (Abcam) overnight at 4°C. The slides were then incubated with a goat anti-rabbit/mouse secondary antibody (Maxin) at 37°C for 30 min. A DAB Substrate Kit (Maxin) was used carry out the chromogenic reaction. The results were scored by two experienced pathologic examiners who were unaware of the clinicopathologic data. The intensity of the YAP1 staining was evaluated using the following criteria: 0, negative; 1, low; 2, medium; 3, high. The extent of the staining was scored as 0, 0% stained; 1, 1% to 25% stained; 2, 26% to 50% stained; and 3, 51% to 100% stained. Five random fields (20× in magnification) were evaluated under a light microscope. The final scores were calculated by multiplying the scores of intensity with that of extent. The staining results were divided into two grades by final scores: 0 to 2, low staining; 3 to 9, high staining.
The colony formation assay and the 5'-bromo-2'-deoxyuridine (BrdU) incorporation assay
A colony formation assay was carried out as described previously [21] . In brief, a six-well plate was seeded at a density of 800 cells per well. The plates were maintained at 37°C in a humidified incubator, and the culture medium was replaced every 3 days. After 2 weeks, the cells were stained with 0.5% Crystal Violet and the average colony number of five random fields (4× in magnification) was counted under a microscope.
A BrdU ELISA kit (Roche) was also used to measure the proliferation activity [22] . Briefly, the cells were cultured in a 96-well plate overnight. Subsequently, BrdU was added to the culture medium for 2 hours. Then, the anti-BrdU-POD binds to the BrdU incorporated into newly synthesized DNA. Finally, the reaction product was quantified by the absorbance value (A370nm-A490nm).
Statistical analysis
Statistical analyses were carried out using the IBM SPSS Statistics Program 19.0 (Armonk, New York, the United States). Each experiment was performed in triplicate and the values are presented as the mean±SD. Student's t test for unpaired data was used to compare the mean values. Kaplan-Meier curves and log-rank tests were calculated for the YAP1 expression level. Pearson correlations were run to measure the association between pairs of variables. All of the probability values had a statistical power level of 90% and a 2-sided level of 5%. P<0.05 was considered significant.
Cellular
Physiology and Biochemistry Cellular Physiology and Biochemistry
Results
miR-497 inhibits cell proliferation in NSCLC
The expression level of miR-497 was detected in 8 NSCLC cell lines using qRT-PCR. Three cell lines (A1395, and SK-MES-1 and H520) had high levels of miR-497, whereas other cell lines (H358, A549, H1975, H1299 and H460) presented relative lower expression levels (Fig. 1A) . To explore the role of miR-497 in proliferation, H520 (high miR-497 expression) and H1299 (low miR-497 expression) cells were transiently transfected with anti-miR-497 siRNA and miR-497 mimics, respectively. Then, the transfected cells were subjected to proliferation assays. BrdU incorporation assays were performed, and growth curves were drawn. As shown in Fig. 1B , H520 cells transfected with anti-miR-497 showed significantly higher growth activity than the control cells (H520 with scrambled RNA). The differences emerged at 24 h and peaked at 48 h after transfection. In contrast, the H1299 cells with the miR-497 mimic had significantly reduced proliferation activities compared to H1299 cells transfected with NTC at 48 h and 72 h. H520 cells transfected with anti-miR-497 siRNAs displayed an elevated Ki-67 level, whereas H1299 cells transfected with miR-497 mimics showed decreased Ki-67 expression (Fig. 1C) . Additionally, in the colony formation assays, the transfection of the miR-497 mimic reduced colonies (Fig. 1D, P<0 .05), whereas antimiR-497 siRNAs increased the number of colonies (Fig. 1D, P<0 .05). Taken together, these data revealed a critical role of miR-497 in the proliferation of NSCLC cells. . The mean ± SD of normalized C T was from 3 independent experiments. B, proliferation activity was evaluated with BrdU incorporation assays in H520 and H1299 cells that were transiently transfected with siRNA and mimic for miR-497, respectively. Scrambled RNA and non-targeting control RNA was used as a control. The mean ± SD of the absorbance was from 3 independent experiments. Forty-eight hours after transfection, H520 and H1299 cells were used to detect the proliferation marker, Ki-67 (C), and the colony formation assay (D). The colonies were stained with crystal violet after an incubation for 2 weeks (left). The mean ± SD of the colonies from 3 independent experiments is shown to the right. *, P<0.05; **, P<0.001. 
YAP1 is negatively regulated by miR-497
The 3483 nt-3'-UTR of YAP1 was screened out for complementarity with the sequence of miR-497 via a bioinformatic search in Targetscan. A 7mer-m8 (exact match to positions 2-8 of the mature miRNA) target sequence for miR-497 at nt 162-168 of the 3'-UTR of YAP1 was found.
A wild type or mutant 3'-UTR of the YAP1 gene was inserted into the dual luciferase vector pmirGLO ( Fig. 2A) . In addition to the luciferase plasmid, the miR-497 mimics or antimiR-497 SiRNAs were cotransfected into HEK293T cells. The transfection efficiency was validated using qRT-PCR (Fig. 2B & 2C, top) . The results of the luciferase assays showed that syn-miR-497 mimics significantly inhibited the luciferase activity of the wild type 3'-UTR reporter gene by 79.1% ± 6.7% in HEK293T cells. As expected, syn-miR-497 did not influence the luciferase activity of the mutant 3'-UTR reporter gene (Fig. 2B, bottom) . In contrast, the luciferase activity of the reporter gene was significantly elevated when antimiR-497 siRNAs were cotransfected with the wild-type reporter (Fig. 2C, bottom) . These results confirmed that YAP1 was a direct target gene of miR-497. In addition, transfection with the syn-miR-497 mimics led to a 58.3% reduction of YAP1 protein expression in H1299 cells (Fig. 2D) . In contrast, anti-miR-497 siRNAs elevated the protein level of YAP1 by 41.6% in H520 cells (Fig. 2E ). Additionally, the mRNA level of YAP1 was negatively regulated by miR-497 (Fig. 2F) . Taken together, these data suggest that miR-497 suppresses YAP1 expression by directly targeting the 3'-UTR of the YAP1 gene.
miR-497 suppresses the proliferation of NSCLC by targeting YAP1
The correlation of the expression levels of miR-497 and YAP1 in 8 NSCLC cell lines was investigated. Five cell lines (H358, A549, H1975, H1299 and H460) had low miR-497 levels and high YAP1 levels. In contrast, the other three cell lines (A1395, SK-MES-1 and H520) had high miR-497 levels and low YAP1 levels. Pearson correlation analysis revealed that the level of YAP1 significantly correlated to that of miR-497 in these cell lines ( Fig. 3A ; rs = -0.830, P = 0.011).
Subsequently we investigated whether miR-497 inhibits proliferation by directly targeting YAP1. Syn-miR-497 and pcDNA 3.1-YAP1 were cotransfected into H1299 cells, with NTC and pcDNA 3.1 vector as controls. The proliferation activity of the transfected cells was assessed using BrdU assays (Fig. 3B) . The results revealed that syn-miR-497 significantly reduced the proliferation activity of H1299 cells compared to NTC. However, pcDNA 3.1-YAP1 could partially antagonize this growth-inhibiting effect of syn-miR-497. Moreover, the protein levels of c-myc, a downstream gene of YAP1 [23] , as well as Ki-67, which is usually used as a proliferation marker [24] , were detected 48 hours after cotransfection (Fig. 3C) . As expected, the levels of c-myc and Ki-67 in H1299 cells cotransfected with pcDNA 3.1 and syn-miR-497 were lower than pcDNA 3.1 and NTC. Interestingly, when pcDNA 3.1-YAP1 was cotransfected with syn-miR-497, the levels of c-myc and Ki-67 were not reduced as much as in cells cotransfected with pcDNA 3.1 and syn-miR-497. These data suggested that miR-497 suppresses downstream gene expression and inhibits cell proliferation by targeting YAP1.
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Inverse correlation between YAP1 and miR-497 expression in NSCLC patients
To explore the expression of miR-497 in NSCLC tissues, we examined the miR-497 level in tumor tissues and the corresponding adjacent normal lung tissues in a total of 30 patients with NSCLC (Fig. 4A) . The data showed that 25 of the 30 cases (83.3%) had decreased miR-497 levels in tumor tissues compared to the adjacent normal tissues. The expression levels of miR-497 and YAP1 were detected in tumor tissues of 51 patients with NSCLC by qRT-PCR and immunohistochemical staining, respectively (Fig. 4A) . Pearson correlation analysis revealed that the expression of miR-497 was inversely correlated with YAP1 in the 51 patients (rs = -0.526; P < 0.001; Fig.4C ).
The relationship between the level of miR-497 and the clinicopathologic parameters of NSCLC are summarized in Table 1 . The 51 patients were stratified into two groups by the median value of the miR-497 level. No significant correlation was noticed between the miR497 level and age, gender, pathologic type, pN stating, or differentiation. However, pT staging had a significant association with the miR-497 level. In addition, we investigated the prognostic significance of miR-497 in these patients with NSCLC. Kaplan-Meier analysis revealed that the patients with a low miR-497 level had poorer survival (Fig. 4D) . The median overall survival of the low miR-497 group and high miR-497 group was 25.08 ± 3.67 months and 31.64 ± 2.08 months, respectively (P=0.022). These findings support our finding that miR-497 promotes NSCLC progression via targeting YAP1. The results are presented as the division of the C T value of tumor specimens divided by the corresponding normal tissues. The mean ± SD was from 3 independent experiments. C, Pearson analysis for the correlation of YAP1 and miR-497 expression levels in patients with NSCLC (n=51; R=-0.528; p<0.001). YAP1 staining intensity from 24 random regions in A was quantified using ImageJ software. miR-497 expression levels were normalized to U6 and presented as the ΔC T value. The mean ± SD was calculated from 3 independent experiments. D. Kaplan-Meier analysis of survival of 51 patients with NSCLC (P =0.022 by log-rank test) according to the expression of miR-497. The vertical bars on the survival curves indicate censored cases.
